Flanvotumab (IMC-20D7S) is a humanized monoclonal antibody targeting tyrosinase-related protein (TYRP1), exhibiting potent antitumor activity through natural killer-mediated and antibody-dependent cell-mediated cytotoxicity (ADCC).
Purity:
>95%
CAS Number:
[1188277-05-5]
Target:
Tyrosinase
T77011
* VAT and and shipping costs not included. Errors and price changes excepted